IP Library › Granted Patent US 10,993,890
Granted Patent B2
US 10,993,890 · App. 16/299,454 · Granted May 4, 2021

Antifungal solution and foot wipe

Inventors: Jesse Villarreal, Jr. (Canby, OR); Carolyn Shawn Murphy (Harrison, OH)
Assignee: PELLI SKIN CO., LLC
A61K8/0208A61K8/46A61K8/4973A61K8/9789A61K9/0014A61K9/7007A61K31/325A61K31/357A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,993,890
App. No.
16/299,454
Granted
May 4, 2021
Kind
B2
Abstract

A treatment solution has an antifungal agent, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution is essentially free of alcohol. A wipe has a substrate, a treatment solution impregnated into the substrate, the treatment solution including an antifungal agent, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution has an alcohol content of 6 wt % or below of the total solution. A treatment solution, has an antifungal agent, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution has an alcohol content of 6 wt % or below of the total solution.

Claims (20)

1. A treatment solution, comprising:

an antifungal agent comprising a naphthyl thiocarbamate;

a carrier fluid; and

an antifungal agent solvent comprising a dioxolane solvent miscible with the carrier and having a log Kow with a range of −1 to 1 the dioxolane comprising one selected from the group selected from: 1,3-dioxolane, 4-Methyl-1,3-dioxolane, 2-methyl-1,3-dioxolane, (2-Methyl-1,3-dioxolane-4-yl) methanol, 1,3-Dioxepane, 1,3-Dioxolane-4-methanol, 5-Hydroxy-1,3-dioxane, Glycrol formal mixture (60:40) of 1,3-Dioxolane-4-methanol:5-Hydroxy-1,3-dioxane, 1,4-dioxane, 1,3-dioxolane-2-one, and mixtures thereof,

wherein the treatment solution has an alcohol content of 1 wt % or below of the total solution.

2. The treatment solution as claimed in claim 1 , wherein the antifungal agent comprises tolnaftate.

3. The treatment solution as claimed in claim 1 , wherein the antifungal agent is tolnaftate having a concentration of at least 1 wt % of the total solution, and the antifungal agent solvent is dioxolane having a concentration in the range of 2 wt % to 4 wt % of the total solution.

4. The treatment solution of claim 1 , wherein the treatment solution further includes at least one of: emollients, surfactants, essential oils, thickening agents, texturizers, preservatives, and exfoliants.

5. The treatment solution of claim 4 , wherein the treatment solution further includes at least one of peppermint and eucalyptus.

6. A treatment solution, comprising

an antifungal agent comprising a naphthyl thiocarbamate;

a carrier fluid; and

an antifungal agent solvent comprising a dioxolane solvent miscible with the carrier fluid and having a log Kow with a range of −1 to 1 the dioxolane comprising one selected from the group consisting of: 1,3-dioxolane, 4-Methyl-1,3-dioxolane, 2-methyl-1,3-dioxolane, (2-Methyl-1,3-dioxolane-4-yl) methanol, 1,3-Dioxepane, 1,3-Dioxolane-4-methanol, 5-Hydroxy-1,3-dioxane, Glycrol formal mixture (60:40) of 1,3-Dioxolane-4-methanol:5-Hydroxy-1,3-dioxane, 1,4-dioxane, 1,3-dioxolane-2-one, and mixtures thereof,

wherein the treatment solution has an alcohol content of 6 wt % or below of the total solution.

7. The treatment solution as claimed in claim 6 , wherein the treatment solution has an alcohol content of 5 wt % or below.

8. The treatment solution as claimed in claim 6 , wherein the treatment solution has an alcohol content of 4 wt % or below.

9. The treatment solution as claimed in claim 6 , wherein the treatment solution has an alcohol content of 3 wt % or below.

10. The treatment solution as claimed in claim 6 , wherein the treatment solution has an alcohol content of 2 wt % or below.

11. The treatment solution as claimed in claim 1 , wherein the antifungal agent is terbinafine hydrochloride having a concentration of at least 1 wt % of the total solution, and the dioxolane antifungal agent solvent has a concentration in the range of 2 wt % to 4 wt % of the total solution.

12. The treatment solution of claim 4 , wherein the treatment solution further includes at least one of peppermint and eucalyptus.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2019
From: MURPHY, CAROLYN SHAWN
To: VILLARREAL, JR., JESSE
Reel/Frame 048571/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2019
From: VILLARREAL, JR., JESSE
To: PELLI SKIN CO., LLC
Reel/Frame 048571/0783 →
Continuity (4)
Provisional Application 62782550 · Dec 20, 2018
Provisional Application 62715631 · Aug 7, 2018
Provisional Application 62643627 · Mar 15, 2018
Related Publication 20190282458A1 · Sep 19, 2019